Logo image of ALTUV.PA

BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock

1.478 EUR
+0.01 (+0.82%)
Last: 12/31/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALTUV. ALTUV was compared to 109 industry peers in the Machinery industry. ALTUV has an average financial health and profitability rating. ALTUV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALTUV had positive earnings in the past year.
In the past year ALTUV had a positive cash flow from operations.
Each year in the past 5 years ALTUV has been profitable.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.37%, ALTUV is doing worse than 65.14% of the companies in the same industry.
ALTUV's Return On Equity of 2.44% is on the low side compared to the rest of the industry. ALTUV is outperformed by 67.89% of its industry peers.
With a Return On Invested Capital value of 2.84%, ALTUV is not doing good in the industry: 72.48% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ALTUV is significantly below the industry average of 8.95%.
Industry RankSector Rank
ROA 1.37%
ROE 2.44%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ALTUV's Profit Margin of 2.64% is in line compared to the rest of the industry. ALTUV outperforms 42.20% of its industry peers.
ALTUV's Profit Margin has declined in the last couple of years.
ALTUV has a Operating Margin of 5.92%. This is comparable to the rest of the industry: ALTUV outperforms 45.87% of its industry peers.
ALTUV's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 38.14%, ALTUV is in line with its industry, outperforming 45.87% of the companies in the same industry.
In the last couple of years the Gross Margin of ALTUV has grown nicely.
Industry RankSector Rank
OM 5.92%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

ALTUV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALTUV has about the same amount of shares outstanding.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALTUV has an Altman-Z score of 1.42. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALTUV (1.42) is worse than 67.89% of its industry peers.
The Debt to FCF ratio of ALTUV is 7.66, which is on the high side as it means it would take ALTUV, 7.66 years of fcf income to pay off all of its debts.
ALTUV has a Debt to FCF ratio (7.66) which is in line with its industry peers.
ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.39, ALTUV perfoms like the industry average, outperforming 46.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.66
Altman-Z 1.42
ROIC/WACC0.4
WACC7.12%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

ALTUV has a Current Ratio of 2.07. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
ALTUV has a Current ratio of 2.07. This is in the better half of the industry: ALTUV outperforms 77.98% of its industry peers.
A Quick Ratio of 1.33 indicates that ALTUV should not have too much problems paying its short term obligations.
ALTUV has a better Quick ratio (1.33) than 75.23% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.33
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 200.00% over the past year.
Looking at the last year, ALTUV shows a decrease in Revenue. The Revenue has decreased by -7.99% in the last year.
Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 3.57% on average per year.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.11, ALTUV is valued on the expensive side.
ALTUV's Price/Earnings ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 63.30% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, ALTUV is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.35, which indicates a correct valuation of ALTUV.
Based on the Price/Forward Earnings ratio, ALTUV is valued a bit cheaper than 63.30% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. ALTUV is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.11
Fwd PE 14.35
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ALTUV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 64.22% of the companies in the same industry.
ALTUV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALTUV is cheaper than 81.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.63
EV/EBITDA 8.76
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.50%, ALTUV has a reasonable but not impressive dividend return.
ALTUV's Dividend Yield is a higher than the industry average which is at 1.56.
Compared to an average S&P500 Dividend Yield of 2.00, ALTUV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

BIO-UV GROUP SAS

EPA:ALTUV (12/31/2025, 7:00:00 PM)

1.478

+0.01 (+0.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)09-18 2025-09-18
Earnings (Next)01-22 2026-01-22/amc
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.91M
Revenue(TTM)37.81M
Net Income(TTM)1.00M
Analysts86.67
Price Target3.06 (107.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 21.11
Fwd PE 14.35
P/S 0.55
P/FCF 7.63
P/OCF 4.38
P/B 0.51
P/tB 4.26
EV/EBITDA 8.76
EPS(TTM)0.07
EY4.74%
EPS(NY)0.1
Fwd EY6.97%
FCF(TTM)0.19
FCFY13.1%
OCF(TTM)0.34
OCFY22.81%
SpS2.67
BVpS2.9
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.14
Profitability
Industry RankSector Rank
ROA 1.37%
ROE 2.44%
ROCE 3.86%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.49%
OM 5.92%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.25%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
ROICexc(3y)4.1%
ROICexc(5y)3.43%
ROICexgc(3y)16.63%
ROICexgc(5y)12.76%
ROCE(3y)5.32%
ROCE(5y)4.17%
ROICexgc growth 3Y36.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.71%
ROICexc growth 5YN/A
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.66
Debt/EBITDA 3.36
Cap/Depr 79.92%
Cap/Sales 5.37%
Interest Coverage 250
Cash Conversion 99.79%
Profit Quality 274%
Current Ratio 2.07
Quick Ratio 1.33
Altman-Z 1.42
F-Score7
WACC7.12%
ROIC/WACC0.4
Cap/Depr(3y)64.39%
Cap/Depr(5y)89.92%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6706.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.27%
EBIT growth 3Y28.77%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.4%
FCF growth 3Y105.48%
FCF growth 5YN/A
OCF growth 1Y18.95%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status of BIO-UV GROUP SAS (ALTUV.PA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for BIO-UV GROUP SAS?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


What is the valuation of BIO-UV GROUP SAS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIO-UV GROUP SAS (ALTUV.PA) is 21.11 and the Price/Book (PB) ratio is 0.51.


What is the financial health of BIO-UV GROUP SAS (ALTUV.PA) stock?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.